PSA testing put back on the table by cancer doctors
Regular prostate testing recommended by cancer doctors despite controversy.
Prostate cancer screening for those with at least 10 years to live should be considered, says the largest society of cancer doctors.
Contradicting a recent warning against regular prostate screening by the US Preventive Services Task Force (USPSTF), the American Society of Clinical Oncology said that men should have the option of being tested.
"Screening should be discussed with men who have a longer life expectancy, so that men can make an informed decision," said Dr. Ethan Basch, a prostate cancer expert and co-chair of the American Society of Clinical Oncology (ASCO) panel, said Reuters.
The USPSTF’s note on prostate cancer screening last May sparked controversy among many specialists.
More from GlobalPost: Peru, Latin America’s hidden growth story
Urologists and cancer experts said the move could condemn many men to death who could otherwise be screened and treated, said ABC News.
USPSTF said that the PSA test is a public health disaster, costing the health care system while having mixed results in terms of cancer survival rates, reported Reuters.
ASCO used the same data as USPSTF and found that in the European study that was conducted, PSA tests actually did cut cancer deaths.
The new advice was published in the Journal of Clinical Oncology.
There is no paywall on the story you just read because a community of dedicated listeners and readers have contributed to keep the global news you rely on free and accessible for all. Will you join the 226 donors who have supported The World so far? From now until Dec. 31, your gift will help us unlock a $67,000 match. Donate today to double your impact!